Drug class in one race
GLP-1/glucagon receptor (dual) drugs for Obesity
5 tracked GLP-1/glucagon receptor (dual) drugs in the Obesity race. The class explanation lives on the GLP-1/glucagon receptor (dual) page; the full indication pipeline across every mechanism is on the Obesity page.
2 Phase 31 Phase 21 Phase 1/21 Phase 1
Head-to-head evidence: AZD9550 vs DA-1726 · AZD9550 vs PB-718 · AZD9550 vs mazdutide · AZD9550 vs survodutide · DA-1726 vs PB-718 · DA-1726 vs mazdutide